Birth weight was 1,630 g ( ! 3rd percentile) and length was 41 cm ( ! 3rd percentile). Apgar score was 5/6 * /8 * ( * under CPAP (continuous positive airway pressure) ventilation). The head was dolichocephalic with pale facial skin, hypertelorism, flattened nasal bridge, and dysplastic ears with preauricular sinuses and tags ( fig. 3 ). There was a medial cleft palate. Upper arms were rotated inwards. Anal atresia was present without fistula. External genitalia showed coronary hypospadias with scrotum bipartitum ( fig. 3 ) .
Chest X-ray revealed increased perihilar streaking. Echocardiography demonstrated persistent foramen ovale and patent ductus arteriosus (Botalli duct) with systolic-diastolic low flow shunt, enlarged right ventricle and pulmonary artery and aortic stenosis.
Magnetic resonance imaging (MRI) showed heart, liver and spleen location and size within normal limits. The right kidney was missing, the left kidney was hypoplastic (2 cm), the left ureter was markedly dilated. Cranial MRI confirmed medial cleft palate and revealed hypoplasia of the corpus callosum. Sonography confirmed absence of the right and hypoplasia of the left kidney, ureteral dilatation, and pronounced dilatation of the rectum owing to anal atresia. Newborn screening for inborn errors of metabolism was unremarkable.
Initially, due to moderate dyspnoea, a CPAP-device was implemented, but increasing CO 2 -retention required intubation. Anal atresia was treated via installation of a descendostoma. Postnatal cardiac function was not impaired. Due to renal agenesis and hypoplasia, renal function deteriorated soon after birth, leading to increased creatinine (max. 3.3 mg/dl) and urea (max. 135 mg/dl) within the first days of life. Furosemide treatment was started at day 5 but could not compensate for further deterioration of renal function, leading to anuria and formation of anasarca. Concomitantly, pleural effusions and respiratory insufficiency required repeated paracentesis. The aggravating clinical situation and possible interventions were discussed with the family who decided against further intensification of therapy. The child died 29 days after birth. According to the parents' wishes, autopsy was not performed. His parents felt grateful for the time they were allowed to share with him.
Cytogenetic and Molecular Cytogenetic Analysis
Postnatally, chromosome analyses were performed on phytohaemagglutinin-stimulated peripheral blood lymphocytes as well as on fibroblasts from skin biopsy using conventional techniques. GTG-and RHG-banded chromosomes (resolution: 500 bands) showed an additional chromosome 22 in all 60 metaphases examined (47,XY,+ 22; fig. 4 ). FISH analysis using the probes MD DGCR (specific for 22q11.2) and SHANK3 (specific for 22q13) (Kreatech Diagnostics, Poseidon DNA Probes) confirmed trisomy 22 ( fig. 5 ) . To rule out possible additional genomic rearrangements, array CGH analysis was performed after obtaining consent from the parents. Genomic DNA was isolated from pieces of umbilical cord following the standard high salt-based rapid DNA isolation method [Aljanabi and Martinez, 1997] . Array CGH was performed using a CGX-12 cytogenetics array (Roche NimbleGen, Inc., Madison, Wisc., USA). This array platform contains 135K oligonucleotide probes covering the whole genome at an average resolution of 35 kb, as well as clinically significant regions at 10 kb. The labeling of both test and reference DNA and hybridization were performed according to the manufacturer's instructions. The array was scanned using the NimbleGen MS 200 scanner. The array data analyses were performed using Genoglyphix Software (Signature Genomics Laboratories, Spokane, Wash., USA) and probe sequence annotation was based on NCBI Build 36.1 (hg18) of the human genome.
The array CGH in the patient showed an elevation in the signal intensity of probes (logR ϳ 0.5) contiguously present along the long arm of chromosome 22 (22q11.21-22q13.33), indicating a copy gain, consistent with the cytogenetic observation of 3 copies of chromosome 22 ( fig. 6 ). No further changes were marked that could be categorized as major gains or losses of chromosomal regions. Furthermore, a SNP array analysis was carried out to validate the duplication of chromosome 22 through its B allele frequency profile (data not shown). 
Discussion
Analyzing the incidence and spectrum of chromosome abnormalities in 2,180 spontaneous abortions, Menasha et al. [2005] confirmed trisomy 16 as the most common trisomy in spontaneous abortions (18% of all trisomies), followed closely by trisomy 21 and trisomy 22 (16% of trisomies and ϳ 5% of all spontaneous abortions, respectively).
Prior to the era of molecular cytogenetics, Schinzel [1981] questioned whether full, non-mosaic trisomy 22 would be compatible with intrauterine survival up to term. He suspected that many cases published by that time might rather represent partial trisomies or unbalanced 11; 22 translocations. Indeed, a number of published karyotypes depict one of the 3 putative chromosomes 22 to be smaller than the other two, drawing the diagnosis of complete trisomy 22 into question. Since then, additional techniques (FISH, array technologies) demonstrated that full, non-mosaic trisomy 22 can be compatible with late gestational age, including survival until birth and even beyond. Karyotyping in our case did in fact first raise the suspicion that one of the 3 chromosomes 22 could be incomplete ( fig. 4 ; right karyotype). Yet, SNP array and array CGH analysis confirmed that, regardless of the subtle size difference, all 3 chromosomes 22 were complete ( fig. 6 ). The majority of trisomy 22 errors ( 1 96%) occur during oogenesis, predominantly during the first meiotic division [Hall et al., 2007] . Our family declined investigations aiming at determination of the parental origin of the additional chromosome 22. In addition to free trisomy 22, the literature provides examples of putative isochromosomes and translocations involving chromosome 22 [Voiculescu et al., 1987; Manasse et al., 2000] . Presence of an isochromosome 22 has been described for a trisomy 22 mosaic child [Guze et al., 2004 ]. An early report by Lalchev et al. [1978] on a possible 21; 22 Robertsonian translocation has been considered as 'not convincing in [its] cytogenetic documentation' by Schinzel [1981] . According to Schinzel [1981 Schinzel [ , 2001 , lack of trisomy 22 offspring in families with Robertsonian translocations involving chromosome 22 argues against viability of full trisomy 22. Statistically, however, the number of such families is relatively small, so rare exceptions may still be possible.
Today, the phenotype of children with trisomy 22 appears well-defined, as reviewed by several authors [Bacino et al., 1995; Crowe et al., 1997; Tinkle et al., 2003] . Common features include midface hypoplasia with flat/ broad nasal bridge, dysplastic ears with pits, tags, or poruses, cleft palate, hypertelorism, microcephaly/cranial abnormalities, congenital heart disease, genital abnormalities, and IUGR ( table 1 ) . Additional frequent findings are single umbilical artery, micrognathia, abnormal anus/anal atresia, and malformed kidneys. In individual cases, thyroid isthmus agenesis and absent gall bladder (fetocide at 27 weeks gestation [Gangbo et al., 2004] ), distinct histopathological features of the temporal bone [Miura et al., 2000; Ohtani et al., 2001 ], agenesis of the ductus venosus [Barseghyan et al., 2009] or overlapping phenotypical features with disorders such as Fryns syndrome [Ladonne et al., 1996] or Goldenhar sequence [Kobrynski et al., 1993] have been described. An exceptional report concerns a stillborn child (birth induced at 39 weeks gestation) with alleged trisomy 22 in fetal blood cells (cordocentesis) and skin culture with prenatal IUGR but surprising lack of developmental defects [Morrison et al., 1998 ].
Several reports deal with prenatal sonographic findings [Sepulveda et al., 2003; Stressig et al., 2005; Sifakis et al., 2008; Schwendemann et al., 2009] and maternal serum biochemical markers in trisomy 22 pregnancies [Sifakis et al., 2008 ]. Schwendemann's report also mentions a live-born child with trisomy 22, but no further clinical details are given. Sonographically identified anomalies include IUGR (cf. fig. 1 ), limb hypoplasia, craniofacial Following Tinkle et al. [2003] , entries are sorted by publication year and include the 6 most recently published cases (italics). Further patient details are given in the original publications and in the synopses provided by, e.g., Tinkle et al. [2003] or Crowe et al. [1997] . + = Present; -= absent; no symbol = unknown.
a The karyotype of this patient was 47,XX,inv(9)(p11q13),+22, considered as 'trisomy 22 and a pericentric inversion of one chromosome 9, the latter being a normal variant'.
until late gestation or even beyond birth remains unsolved. Undetected confined placental mosaicism [Robinson and Kalousek, 1996] or mosaicism in fetal tissues other than blood or skin tested might explain some of the surviving cases. Even reports proving trisomy 22 not only in blood cells or fibroblasts but also in cytotrophoblast cells [Bacino et al., 1995; Hengstschlager et al., 2001] do not exclude the possibility of undetected somatic mosaicism. Most cases of trisomy 22 are of maternal origin, but as to survival the parental origin of the extra chromosome 22 does not seem to play a crucial role since there have been examples for both maternal [Petersen et al., 1987; Mihci et al., 2007] and paternal origin [Feret et al., 1991] .
malformations, cardiac anomalies and increased nuchal translucency/cystic hygroma. The plethora of features observed might in part be due to different screening times. In addition, karyotype analysis based on chorionic villus sampling carries the well-known risk of missing low level mosaicism, such as proven by follow-up amniocentesis in some of the recently reported cases [Wolstenholme et al., 2001; Sifakis et al., 2008] . Differentiation between mosaic and non-mosaic trisomy 22 is important, particularly with respect to counseling issues regarding life-expectancy and possible complications which are usually milder in mosaic cases [Crowe et al., 1997; Leclercq et al., 2010] . As illustrated in figure 7 , survival of live-born children with non-mosaic trisomy 22 is severely limited, ranging from hours post partum to a maximum of 3 years (observed in 2 cases) [Kukolich et al., 1989; Rao et al., 2003] . Median survival of the 30 cases summarized in figure 7 was 3.5 days. Common causes of death are respiratory/ cardiorespiratory failure and infection [Tinkle et al., 2003] .
In summary, the vast majority of trisomy 22 zygotes end up as spontaneous abortions. Only a minority of fetuses survive until term. Medium postpartum survival amounts to 3-4 days, and maximum survival reported is 3 years. There is a rather consistent pattern of IUGR combined with multiple and severe malformations. The question why a small proportion of trisomy 22 fetuses survive [Tinkle et al., 2003] . Inset: Data for children with trisomy 22 living no longer than 48 h (enlarged time scale).
